MASECO Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MASECO Private Wealth's BMY Position: Q2 2026 in Review
MASECO Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 8.8% in Q2 2026, selling an estimated $7.46K and leaving 1,352 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #148.
MASECO Private Wealth first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $256K in Q2 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- MASECO Private Wealth held 1,352 shares of Bristol-Myers Squibb worth $77.9K as of Q2 2026.
- MASECO Private Wealth sold 130 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.46K.
- Bristol-Myers Squibb made up ﹤0.01% of MASECO Private Wealth's portfolio in Q2 2026, its #148 holding.
- MASECO Private Wealth first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
- MASECO Private Wealth's Bristol-Myers Squibb position peaked at $256K in Q2 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.